OPN binding to integrin activates nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB)-mediated signaling, which modulates the MAPK pathway and upregulates MMP-9, causing increased cancer cell migration and invasion [87,88,89,90]. This evidence concerns the gene MMP9 and cancer.